Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The combination of a half-course of miltefosine and a half-course of antimony will be
evaluated for efficacy and tolerance. The combination of miltefosine and antimony is chosen
because these are now the two standard agents in Bolivia, and in vitro the combination was
additive to mildly synergistic against a standard leishmania strain.
Phase:
Phase 2
Details
Lead Sponsor:
Centro de Investigaciones Bioclínicas de la Fundación Fader